Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial of ixabepilone in patients with advanced cisplatin-refractory germ cell tumors has completed, evaluating outcomes across central nervous system/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Extragonadal Germ Cell Tumor
• Ovarian Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• Ixabepilone (ixabepilone)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor | Phase 2 | Status: COMPLETED